Healthcare provider profile · identity verified

Sandeep Bal, MD

Internal Medicine · MOUNT VERNON, WA · NPI 1386819449

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	510	137
Losartan Potassium	Losartan Potassium	382	104
Levothyroxine Sodium	Levothyroxine Sodium	358	99
Amlodipine Besylate	Amlodipine Besylate	327	91
Lisinopril	Lisinopril	320	92
Gabapentin	Gabapentin	310	83
Omeprazole	Omeprazole	310	88
Hydrochlorothiazide	Hydrochlorothiazide	240	68
Sertraline Hcl	Sertraline Hcl	193	55
Metoprolol Succinate	Metoprolol Succinate	174	49
Duloxetine Hcl	Duloxetine Hcl	173	41
Pantoprazole Sodium	Pantoprazole Sodium	163	43
Metformin Hcl	Metformin Hcl	158	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	151	43
Simvastatin	Simvastatin	151	41
Ozempic	Semaglutide	126	16
Jardiance	Empagliflozin	110	27
Trazodone Hcl	Trazodone Hcl	109	32
Rosuvastatin Calcium	Rosuvastatin Calcium	100	33
Pravastatin Sodium	Pravastatin Sodium	84	23
Metoprolol Tartrate	Metoprolol Tartrate	82	22
Citalopram Hbr	Citalopram Hydrobromide	80	22
Lovastatin	Lovastatin	79	22
Metformin Hcl Er	Metformin Hcl	77	22
Albuterol Sulfate Hfa	Albuterol Sulfate	76	34
Tamsulosin Hcl	Tamsulosin Hcl	76	21
Pregabalin	Pregabalin	73	12
Allopurinol	Allopurinol	71	21
Potassium Chloride	Potassium Chloride	70	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	68	19
Estradiol	Estradiol	63	26
Fluticasone Propionate	Fluticasone Propionate	63	24
Furosemide	Furosemide	61	26
Oxycodone Hcl	Oxycodone Hcl	61	14
Famotidine	Famotidine	60	23
Warfarin Sodium	Warfarin Sodium	60	18
Eliquis	Apixaban	58	14
Alprazolam	Alprazolam	57	16
Tramadol Hcl	Tramadol Hcl	54	12
Celecoxib	Celecoxib	53	12
Atenolol	Atenolol	50	13
Fluoxetine Hcl	Fluoxetine Hcl	50	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	18
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	45	14
Zolpidem Tartrate	Zolpidem Tartrate	45	11
Clopidogrel	Clopidogrel Bisulfate	43	suppressed
Morphine Sulfate Er	Morphine Sulfate	43	suppressed
Bupropion Xl	Bupropion Hcl	41	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Spironolactone	Spironolactone	41	13
Tizanidine Hcl	Tizanidine Hcl	41	17
Meloxicam	Meloxicam	39	23
Glipizide Er	Glipizide	38	12
Glipizide	Glipizide	37	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Carvedilol	Carvedilol	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	11
Montelukast Sodium	Montelukast Sodium	33	suppressed
Finasteride	Finasteride	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	17
Acyclovir	Acyclovir	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Cephalexin	Cephalexin	29	25
Azithromycin	Azithromycin	27	23
Gemfibrozil	Gemfibrozil	26	suppressed
Lorazepam	Lorazepam	26	14
Ondansetron Odt	Ondansetron	26	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Arnuity Ellipta	Fluticasone Furoate	23	suppressed
Prednisone	Prednisone	23	18
Azelastine Hcl	Azelastine Hcl	22	11
Clonazepam	Clonazepam	22	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Nystatin	Nystatin	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	12
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Topiramate	Topiramate	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Nadolol	Nadolol	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Chlorthalidone	Chlorthalidone	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Naproxen	Naproxen	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error